IDAC THERANOSTICS, INC.
4Patents
4Active
4Granted
44Portfolio score
Filing activity: Apr 7, 2015 → Nov 7, 2016
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10746726B2 | Method for assessing therapeutic effect of anti-cancer agent having anti-CD4 antibody as active ingredient | Physics | 1 | Active |
| US10709727B2 | Antiviral drugs | Emerging Cross-Sectional Technologies | 0 | Active |
| US10738352B2 | Method for analyzing nucleic acid derived from single cell | Chemistry; Metallurgy | 0 | Active |
| US11168137B2 | Method for reducing side effects of immune checkpoint control agent | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.